|Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping|
ML Cher, GS Bova, DH Moore, EJ Small, PR Carroll, SS Pin, JI Epstein, ...
Cancer research 56 (13), 3091-3102, 1996
|Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy|
ML CHER, FJ BIANCO, JS LAM, LP DAVIS, DJ GRIGNON, WA SAKR, ...
The Journal of urology 160 (4), 1387-1391, 1998
|CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: the role of bone microenvironment‐associated CXCL12|
SR Chinni, S Sivalogan, Z Dong, JCT Filho, X Deng, RD Bonfil, ML Cher
The Prostate 66 (1), 32-48, 2006
|Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone|
JA Nemeth, JF Harb, U Barroso, Z He, DJ Grignon, ML Cher
Cancer research 59 (8), 1987-1993, 1999
|Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis|
JA Nemeth, R Yousif, M Herzog, M Che, J Upadhyay, B Shekarriz, ...
Journal of the National Cancer Institute 94 (1), 17-25, 2002
|Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer|
ML Cher, D Macgrogan, R Bookstein, JA Brown, RB Jenkins, RH Jensen
Genes, Chromosomes and Cancer 11 (3), 153-162, 1994
|Prostate cancer: the use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy|
JS Wolf, M Cher, M Dall'Era, JC Presti, H Hricak, PR Carroll
The Journal of urology 153 (3S), 993-999, 1995
|Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM|
D Kong, E Heath, W Chen, ML Cher, I Powell, L Heilbrun, Y Li, S Ali, ...
PloS one 7 (3), e33729, 2012
|Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment|
BF Sloane, S Yan, I Podgorski, BE Linebaugh, ML Cher, J Mai, ...
Seminars in cancer biology 15 (2), 149-157, 2005
|Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis|
ML Cher, HR Biliran, S Bhagat, Y Meng, M Che, J Lockett, J Abrams, ...
Proceedings of the National Academy of Sciences 100 (13), 7847-7852, 2003
|Lycopene and soy isoflavones in the treatment of prostate cancer|
U Vaishampayan, M Hussain, M Banerjee, S Seren, FH Sarkar, J Fontana, ...
Nutrition and cancer 59 (1), 1-7, 2007
|Platelet‐derived growth factor‐D overexpression contributes to epithelial‐mesenchymal transition of PC3 prostate cancer cells|
D Kong, Z Wang, SH Sarkar, Y Li, S Banerjee, A Saliganan, HRC Kim, ...
Stem Cells 26 (6), 1425-1435, 2008
|Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1 …|
M Toth, MM Bernardo, DC Gervasi, PD Soloway, Z Wang, HF Bigg, ...
Journal of Biological Chemistry 275 (52), 41415-41423, 2000
|CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone|
SR Chinni, H Yamamoto, Z Dong, A Sabbota, RD Bonfil, ML Cher
Molecular Cancer Research 6 (3), 446-457, 2008
|Circulating tumor cells: finding the needle in the haystack|
X Zhe, ML Cher, RD Bonfil
American journal of cancer research 1 (6), 740, 2011
|Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer|
EL Gheiler, MV Tefilli, R Tiguert, D Grignon, ML Cher, W Sakr, JE Pontes, ...
Urology 51 (5), 789-795, 1998
|Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand …|
Y Li, O Kucuk, M Hussain, J Abrams, ML Cher, FH Sarkar
Cancer research 66 (9), 4816-4825, 2006
|PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling|
MK Conley-LaComb, A Saliganan, P Kandagatla, YQ Chen, ML Cher, ...
Molecular cancer 12 (1), 1-10, 2013
|Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue|
Z Dong, RD Bonfil, S Chinni, X Deng, JC Trindade Filho, M Bernardo, ...
The American journal of pathology 166 (4), 1173-1186, 2005
|Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein|
Y Li, M Che, S Bhagat, KL Ellis, O Kucuk, DR Doerge, J Abrams, ML Cher, ...
Neoplasia 6 (4), 354-363, 2004